Opko Health (OPK) Ratios
Opko Health Ratios
MX:OPK's free cash flow for Q2 2026 was $-46.50M. For the 2026 fiscal year, MX:OPK's free cash flow was decreased by $-3.00M and operating cash flow was $-43.50M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 3.97 | 3.43 | 1.55 | 1.85 | 2.49 |
| Quick Ratio | 3.52 | 3.13 | 1.22 | 1.50 | 2.23 |
| Cash Ratio | 2.52 | 2.24 | 0.48 | 0.72 | 0.41 |
| Solvency Ratio | -0.20 | 0.05 | -0.13 | -0.36 | 0.07 |
| Operating Cash Flow Ratio | -1.22 | -0.95 | -0.14 | -0.45 | 0.12 |
| Short-Term Operating Cash Flow Coverage | -7.81 | -12.22 | -1.03 | -2.60 | 2.61 |
| Net Current Asset Value | $ -82.10M | $ -172.68M | $ -313.00M | $ -211.09M | $ 108.42M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.22 | 0.23 | 0.16 | 0.14 | 0.11 |
| Debt-to-Equity Ratio | 0.34 | 0.37 | 0.24 | 0.20 | 0.15 |
| Debt-to-Capital Ratio | 0.25 | 0.27 | 0.19 | 0.16 | 0.13 |
| Long-Term Debt-to-Capital Ratio | 0.23 | 0.24 | 0.14 | 0.12 | 0.10 |
| Financial Leverage Ratio | 1.52 | 1.61 | 1.45 | 1.39 | 1.42 |
| Debt Service Coverage Ratio | -0.19 | 1.48 | -1.71 | -4.26 | 2.03 |
| Interest Coverage Ratio | -2.02 | -3.20 | -11.63 | -18.77 | 0.99 |
| Debt to Market Cap | 0.42 | 0.43 | 0.22 | 0.28 | 0.07 |
| Interest Debt Per Share | 0.72 | 0.80 | 0.45 | 0.44 | 0.42 |
| Net Debt to EBITDA | -1.56 | 0.54 | -3.52 | -0.56 | 1.44 |
| Profitability Margins | |||||
| Gross Profit Margin | 21.10% | 43.61% | 36.84% | 28.70% | 32.77% |
| EBIT Margin | -21.90% | 5.20% | -19.78% | -37.79% | 0.27% |
| EBITDA Margin | -6.81% | 18.97% | -7.59% | -26.97% | 4.71% |
| Operating Profit Margin | -36.08% | -21.32% | -18.18% | -22.53% | 1.06% |
| Pretax Profit Margin | -39.78% | -1.45% | -21.36% | -39.03% | -0.83% |
| Net Profit Margin | -37.19% | -7.46% | -21.87% | -32.70% | -1.70% |
| Continuous Operations Profit Margin | -37.19% | -7.46% | -21.87% | -32.70% | -1.70% |
| Net Income Per EBT | 93.49% | 513.65% | 102.41% | 83.80% | 205.70% |
| EBT Per EBIT | 110.23% | 6.81% | 117.45% | 173.21% | -78.15% |
| Return on Assets (ROA) | -11.68% | -2.42% | -9.39% | -15.15% | -1.26% |
| Return on Equity (ROE) | -17.80% | -3.90% | -13.59% | -21.03% | -1.79% |
| Return on Capital Employed (ROCE) | -12.27% | -7.58% | -8.67% | -11.58% | 0.91% |
| Return on Invested Capital (ROIC) | -11.32% | -7.47% | -8.47% | -9.46% | 0.89% |
| Return on Tangible Assets | -24.23% | -6.19% | -39.50% | -59.40% | -3.12% |
| Earnings Yield | -23.85% | -5.22% | -16.64% | -36.54% | -0.97% |
| Efficiency Ratios | |||||
| Receivables Turnover | 4.81 | 4.69 | 6.63 | 6.76 | 6.68 |
| Payables Turnover | 11.65 | 8.54 | 7.83 | 10.69 | 14.54 |
| Inventory Turnover | 7.27 | 7.08 | 8.30 | 9.67 | 13.79 |
| Fixed Asset Turnover | 5.02 | 5.74 | 6.02 | 8.26 | 14.32 |
| Asset Turnover | 0.31 | 0.32 | 0.43 | 0.46 | 0.74 |
| Working Capital Turnover Ratio | 1.34 | 2.47 | 5.95 | 2.98 | 5.54 |
| Cash Conversion Cycle | 94.70 | 86.65 | 52.37 | 57.62 | 55.99 |
| Days of Sales Outstanding | 75.85 | 77.82 | 55.04 | 54.02 | 54.62 |
| Days of Inventory Outstanding | 50.18 | 51.56 | 43.97 | 37.76 | 26.46 |
| Days of Payables Outstanding | 31.33 | 42.73 | 46.63 | 34.15 | 25.10 |
| Operating Cycle | 126.03 | 129.38 | 99.00 | 91.77 | 81.08 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.24 | -0.26 | -0.04 | -0.13 | 0.06 |
| Free Cash Flow Per Share | -0.25 | -0.30 | -0.06 | -0.17 | 0.01 |
| Dividend Paid and CapEx Coverage Ratio | -14.54 | -7.34 | -1.73 | -3.87 | 1.19 |
| Capital Expenditure Coverage Ratio | -14.54 | -7.34 | -1.73 | -3.87 | 1.19 |
| Operating Cash Flow Coverage Ratio | -0.41 | -0.36 | -0.09 | -0.31 | 0.15 |
| Operating Cash Flow to Sales Ratio | -0.29 | -0.26 | -0.03 | -0.09 | 0.02 |
| Free Cash Flow Yield | -20.16% | -20.44% | -3.92% | -13.32% | 0.20% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -4.20 | -19.17 | -6.01 | -2.74 | -103.42 |
| Price-to-Sales (P/S) Ratio | 1.56 | 1.43 | 1.31 | 0.90 | 1.76 |
| Price-to-Book (P/B) Ratio | 0.75 | 0.75 | 0.82 | 0.58 | 1.85 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -4.96 | -4.89 | -25.53 | -7.50 | 504.33 |
| Price-to-Operating Cash Flow Ratio | -5.30 | -5.56 | -40.26 | -9.44 | 81.31 |
| Price-to-Earnings Growth (PEG) Ratio | -0.01 | 0.28 | 0.13 | -0.00 | 0.53 |
| Enterprise Value Multiple | -24.48 | 8.08 | -20.85 | -3.88 | 38.74 |
| Enterprise Value | 1.01B | 1.09B | 1.37B | 1.05B | 3.24B |
| EV to EBITDA | -24.48 | 8.08 | -20.85 | -3.88 | 38.74 |
| EV to Sales | 1.67 | 1.53 | 1.58 | 1.05 | 1.82 |
| EV to Free Cash Flow | -5.30 | -5.24 | -30.71 | -8.78 | 523.75 |
| EV to Operating Cash Flow | -5.66 | -5.96 | -48.44 | -11.04 | 84.44 |
| Tangible Book Value Per Share | 0.36 | 0.04 | -0.19 | -0.07 | 0.39 |
| Shareholders’ Equity Per Share | 1.69 | 1.97 | 1.85 | 2.17 | 2.60 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.07 | -4.13 | -0.02 | 0.16 | -1.06 |
| Revenue Per Share | 0.81 | 1.03 | 1.15 | 1.40 | 2.74 |
| Net Income Per Share | -0.30 | -0.08 | -0.25 | -0.46 | -0.05 |
| Tax Burden | 0.93 | 5.14 | 1.02 | 0.84 | 2.06 |
| Interest Burden | 1.82 | -0.28 | 1.08 | 1.03 | -3.02 |
| Research & Development to Revenue | 0.20 | 0.15 | 0.10 | 0.07 | 0.04 |
| SG&A to Revenue | 0.37 | 0.43 | 0.00 | 0.00 | 0.00 |
| Stock-Based Compensation to Revenue | 0.02 | 0.02 | 0.01 | 0.02 | 0.01 |
| Income Quality | 0.79 | 3.45 | 0.15 | 0.29 | -1.27 |
Currency in USD